This document discusses cerebral edema, including its causes, types, clinical presentation, mechanisms, diagnosis and management. It describes four main types of cerebral edema - cytotoxic, vasogenic, interstitial and osmotic edema. General management includes optimizing head position, ventilation, maintaining perfusion, seizure prophylaxis, fever control and nutrition. Specific treatments include hyperventilation, osmotherapy with mannitol or hypertonic saline, corticosteroids, hypothermia and other adjunct therapies. The goal of osmotherapy is to create an osmotic gradient to reduce brain volume and intracranial pressure.
This document discusses cerebral edema, including its causes, types, clinical presentation, mechanisms, diagnosis and management. It describes four main types of cerebral edema - cytotoxic, vasogenic, interstitial and osmotic edema. General management includes optimizing head position, ventilation, maintaining perfusion, seizure prophylaxis, fever control and nutrition. Specific treatments include hyperventilation, osmotherapy with mannitol or hypertonic saline, corticosteroids, hypothermia and other adjunct therapies. The goal of osmotherapy is to create an osmotic gradient to reduce brain volume and intracranial pressure.
This document discusses cerebral edema, including its causes, types, clinical presentation, mechanisms, diagnosis and management. It describes four main types of cerebral edema - cytotoxic, vasogenic, interstitial and osmotic edema. General management includes optimizing head position, ventilation, maintaining perfusion, seizure prophylaxis, fever control and nutrition. Specific treatments include hyperventilation, osmotherapy with mannitol or hypertonic saline, corticosteroids, hypothermia and other adjunct therapies. The goal of osmotherapy is to create an osmotic gradient to reduce brain volume and intracranial pressure.
This document discusses cerebral edema, including its causes, types, clinical presentation, mechanisms, diagnosis and management. It describes four main types of cerebral edema - cytotoxic, vasogenic, interstitial and osmotic edema. General management includes optimizing head position, ventilation, maintaining perfusion, seizure prophylaxis, fever control and nutrition. Specific treatments include hyperventilation, osmotherapy with mannitol or hypertonic saline, corticosteroids, hypothermia and other adjunct therapies. The goal of osmotherapy is to create an osmotic gradient to reduce brain volume and intracranial pressure.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 40
Cerebral edema
• Cerebral edema represents the accumulation of excess fluid in the
intracellular or extracellular spaces of the brain The Blood-Brain Barrier Blood-Brain barrier (BBB) is exceptionally active system • Endothelial cells can inactivate neuroactive or neurotoxic substances • Regulate microenvironment of the brain, fluid and ions between circulation and brain Interstitial fluid of the brain • low Ca2+ and K+ and high Mg2+ Cerebral edema Four categories • Cytotoxic edema • Vasogenic edema • Interstitial edema • Osmotic edema Clinical presentation • Headache • Tinnitus • Vomiting • Visual obscuration ,visual loss • Papilledema • Diplopia • Hypertension and Bradycardia • Herniation syndromes Cytotoxic edema Cause of cytotoxic edema • Cerebral infarction or ischemia • Meningitis • Reye’s syndrome • Trauma • Seizure • Water intoxication Mechanisms • cytotoxic edema associated with cerebral ischemia - direct role for excess glutamate • dysfunction of the Na+K+-ATPase pump, which permits sodium influx, and activation of the Na+/H+ and Cl–/HCO3– exchangers and the Na+/K+/2Cl– cotransporter contribute to combined neuronal and astrocytic swelling • Loss of ATP and excess glutamate after cerebral ischemia or TBI cause influx of calcium into cell then apoptosis and sodium exchange (3 Na+ per Ca3+) occur • Nitric oxide (NO) from nitric oxide synthase (NOS) • Neuronal NOS produces toxic free radical (early after cytotoxic injury) • Endothelial NOS cause vasodilatation and increase blood flow • Inducible NOS produce NO and free radical at 24-48 hr after injury • Diffuse-weighted MRI signal change within minute after events occur (very early) • In first 12 hour, loss of visible gray-white matter junction and gyral edema occur • 12-24 hour , increase signal in T2- weighted MRI • acute infarcts have a lower ADC than normal brain does, and these ADC maps sensitively indicate early cytotoxic edema Vasogenic edema Cause of vasogenic edema • Primary or secondary brain tumour • Brain abscess and encephalitis • Trauma • Lead poisoning • Late stage of cerebral infarction Mechanisms • Blood-tumor barrier has abnormal micro vessels that lacks of tight junctions cause plasma leakage into brain’s extracellular space • Macromolecular protein produced by tumor has been identified as vascular permeability factor (VPF) / vascular endothelial growth factor (VEGF) • induces capillary permeability, endothelial proliferation, and migration and organization of new capillaries that lack tight junctions. • Glucocorticoids can block permeability-enhancing effects of VPF/VEGF and inhibit tumor cell production of VEGF • High VPF/VEGF gene expression found in glioblastomas, meningiomas and metastases Interstitial edema • Cause of interstitial edema • Hydrocephalus • Mechanism Transependymal flow of water and solute into periventricular extracellular space • Hypodensity area around periventricular white matter in CT scan • Increased signal in FLAIR MRI at interstitial brain surrounding ependyma Osmotic edema • Cause of osmotic edema • Hemodialysis • SIADH • Hypertensive crisis • Water intoxication • Rapid reduction of blood glucose in hyperglycaemic crisis • Mechanism • Hyperosmolarity in brain relatively to circulatory then water move into brain along osmotic gradient • Pathological increase in the water content of the brain • Increased intracranial pressure • Neurological deterioration • Herniation • Death General Measures for Managing Cerebral Edema 1. Optimizing Head and Neck Positions 2. Ventilation and Oxygenation 3. Maintain Intravascular Volume and Cerebral Perfusion 4. Seizure Prophylaxis 5. Management of Fever and Hyperglycemia 6. Nutritional Support Optimizing Head and Neck Positions • 30 ̊elevation of the head in patients is essential for –decreasing CSF hydrostatic pressure. – avoiding jugular compression and impedance of venous outflow from the cranium • to avoid the use of restricting devices and garments around the neck (such as devices used to secure endotracheal tubes), which may impair cerebral venous outflow via compression of the internal jugular veins. • Head position elevation may be detrimental in ischemic stroke, because it may compromise perfusion to ischemic tissue at risk. Ventilation and Oxygenation • Hypoxia and hypercapnia are potent cerebral vasodilator • Maintain PaCO2 > 30 mmHg to support adequate CBF or CPP to brain • maintain PaO2 at approximately 100 mmHg • Pt should be intubated in: 1. GCS scores less than or equal to 8 2. Patients with poor upper airway reflexes be intubated for airway protection. 3. Pulmonary disorder eg: ARDS, aspiration pneumonia • Avoid high PEEP → # systemic venous return , ↓ COP • Blunting of upper airway reflexes Maintain Intravascular Volume and Cerebral Perfusion • Maintain CPP level >60 mmHg CPP=MAP-ICP NORMAL CPP= 70 - 90 mm of Hg • If hypertension avoid use of Potent vasodilators eg. Nitroglycerine, Nitroprusside as they may exacerbate cerebral edema via accentuated cerebral hyperemia due to their direct vasodilating effects on cerebral vessels. Seizure Prophylaxis • Phenytoin are widely used empirically in clinical practice in patients with acute brain injury • Early seizures in TBI can be effectively reduced by prophylactic administration of phenytoin for 1 or 2 weeks. Management of Fever • fever has deleterious effects of on outcome following brain injury, • increases in oxygen demand, • normothermia is strongly recommended in patients with cerebral edema, irrespective of underlying origin. • Acetaminophen (325–650 mg orally, or rectally every 4–6 hours) is the most common agent used • Other surface cooling devices have demonstrated some efficacy Hyperglycemia • Hyperglycemia can also exacerbate brain injury and cerebral edema • current evidence suggests that rigorous glycemic control may be beneficial in all patients with brain injury. Nutritional Support • Unless contraindicated, the enteral route of nutrition is preferred. • Special attention should be given to the osmotic content of formulations, to avoid free water intake that may result in a hypoosmolar state and worsen cerebral edema. Specific Measures for Managing Cerebral Edema 1. Controlled Hyperventilation 2. Osmotherapy 3. Corticosteroid Administration 4. Therapeutic Hypothermia 5. Other Adjunct Therapies Osmotherapy • Mannitol is the osmotic agent universally used to treat cerebral edema • decreases ICPs in two distinct mechanisms • usual dose is 0.25 g to 1 g/kg at 4- to 6-hour intervals and generally effective for 48 to 72 hours. • routine/scheduled use beyond 72 hour can become ineffective because mannitol’s reflection coefficient is 0.9, meaning that even with an intact blood-brain barrier it will slowly leak into the interstitial fluid/brain parenchyma • serum osmolality to a recommended target value of approximately 320mOsm/L HYPERTONIC SALINE • Thirty-millilitre boluses of 23.4% sodium chloride given through a central line over 15 minutes have been shown to be at least as efficacious as mannitol • reflection coefficient of hypertonic saline is 1.0, meaning that if a patient’s blood-brain barrier is intact it will not accumulate in the interstitial space/brain parenchyma • hypertonic saline produces longer duration of ICP lowering with than with mannitol. Glycerol • Glycerol is another useful agent given in oral • Doses: – 30 ml every 4-6 hour or daily IV 50g in 500 ml of 2.5% saline solution – its effectiveness appears to decrease after few days. – It is used in a dose of 0.5-1.0 g/kg body weight. – In unconscious or uncooperative patients it is given by nasogastric tube Therapeutic Basis and Goal of Osmotherapy • fundamental goal of osmotherapy is to create an osmotic gradient to cause egress of water from the brain extracellular (and possibly intracellular) compartment into the vasculature • thereby decreasing intracranial volume (normal brain volume 80%, normal blood volume 10%, and normal CSF volume 10%) and improving intracranial elastance and compliance. • In healthy individuals, serum osmolality (285–295mOsm/L) is relatively constant, and the serum Na+ concentration is an estimate of body water osmolality. • Under ideal circumstances,serum osmolality is dependent on the major cations – (Na+ and K+) – plasma glucose – blood urea nitrogen. • Because urea is freely diffusible across cell membranes, serum Na+ and plasma glucose are the major molecules involved in altering serum osmolality • The goal of using osmotherapy is to maintain a euvolemic or a slightly hypervolemic state. • A serum osmolality in the range of 300 to 320mOsm/L has traditionally been recommended for patients with acute brain injury Corticosteroid • Used in vasogenic edema associated with brain tumors or accompanying brain irradiation and surgical manipulation. • steroids decrease tight-junction permeability and, in turn, stabilize the disrupted BBB. • Glucocorticoids, especially dexamethasone, are the preferred steroidal agents, due to their low mineralocorticoid activity • Steroids deleterious side effects are peptic ulcers, hyperglycemia, impairment of wound healing, psychosis, and immunosuppression. Surgical management • Decompressive Hemicraniotomy - Recommended for large hemispherical infarcts with edema and life threatening brain-shifts. • Ventricular Drainage Thank you